Mendoza, F.A.; DiMarino, A.; Cohen, S.; Adkins, C.; Abdelbaki, S.; Rattan, S.; Cao, C.; Denuna-Rivera, S.; Jimenez, S.A.
Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies. J. Clin. Med. 2022, 11, 6665.
https://doi.org/10.3390/jcm11226665
AMA Style
Mendoza FA, DiMarino A, Cohen S, Adkins C, Abdelbaki S, Rattan S, Cao C, Denuna-Rivera S, Jimenez SA.
Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies. Journal of Clinical Medicine. 2022; 11(22):6665.
https://doi.org/10.3390/jcm11226665
Chicago/Turabian Style
Mendoza, Fabian A., Anthony DiMarino, Sidney Cohen, Christopher Adkins, Shady Abdelbaki, Satish Rattan, Christopher Cao, Susie Denuna-Rivera, and Sergio A. Jimenez.
2022. "Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies" Journal of Clinical Medicine 11, no. 22: 6665.
https://doi.org/10.3390/jcm11226665
APA Style
Mendoza, F. A., DiMarino, A., Cohen, S., Adkins, C., Abdelbaki, S., Rattan, S., Cao, C., Denuna-Rivera, S., & Jimenez, S. A.
(2022). Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies. Journal of Clinical Medicine, 11(22), 6665.
https://doi.org/10.3390/jcm11226665
